A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpuraMarie Scully, Samuel J. Machin, Jamie Cavenagh et al.|Blood|2011Cited by 420
Performance evaluation of the Sysmex haematology XN modular systemCarol Briggs, Samuel J. Machin, Ian Longair et al.|Journal of Clinical Pathology|2012Cited by 187